Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Small Cell Lung Carcinoma 2Neoplasms 2Fallopian Tube Neoplasms 2Uterine Neoplasms 1Triple-negative Metastatic Breast Cancer 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Lung Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Laryngeal Neoplasms 1Glioblastoma 1Colorectal Neoplasms 1Chromosome 5q Deletion Syndrome 1Carcinoma, Ovarian Epithelial 1Carcinoma 1

Interventions

Cyclophosphamide 42fludarabine phosphate 33Peripheral Blood Stem Cell Transplantation 31Busulfan 31Tacrolimus 24Antilymphocyte Serum 24Cyclosporine 22Mycophenolic Acid 20Filgrastim 20Radiotherapy 19Methotrexate 19Melphalan 17Whole-Body Irradiation 13Methylprednisolone 12Etoposide 12Cord Blood Stem Cell Transplantation 11Cytarabine 9Sirolimus 7Flow Cytometry 7Azacitidine 7Alemtuzumab 7Specimen Handling 6Psychiatric Rehabilitation 6Cyclosporins 6Biopsy 6sargramostim 5ruxolitinib 5Thiotepa 5fludarabine 4Rituximab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Myelodysplastic-Myeloproliferative Diseases × adavosertib × Clear all
NCT02666950 2019-09-06

WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome

Mayo Clinic

Phase 2 Completed
3 enrolled 11 charts
MyeloidOther hematologic neoplasm

Chromosome 5q Deletion Syndrome, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡